# FDA Inspection 1267762 - Hubei JXBio Pharmaceutical Co., Ltd - March 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/hubei-jxbio-pharmaceutical-co-ltd/ed5036ce-ce3b-4883-8bbf-6e846ec709d7
Source feed: FDA_Inspections

> FDA Inspection 1267762 for Hubei JXBio Pharmaceutical Co., Ltd on March 14, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267762
- Company Name: Hubei JXBio Pharmaceutical Co., Ltd
- Inspection Date: 2025-03-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267762 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/hubei-jxbio-pharmaceutical-co-ltd/dba36a7e-152d-45da-9d11-277bdedec0e2)
- [FDA Inspection 1250729 - 2024-08-30](https://www.keypedia.com/records/fda_inspections/hubei-jxbio-pharmaceutical-co-ltd/89d40248-9194-4f8f-8a3a-9b3803577ae3)

Company: https://www.keypedia.com/companies/hubei-jxbio-pharmaceutical-co-ltd/0cb70a5f-908f-45e1-bf50-87d4e83281b5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c